Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥352.4B | ¥333.9B | +5.5% |
| Operating Income | ¥45.1B | ¥30.6B | +47.6% |
| Ordinary Income | ¥46.4B | ¥29.6B | +56.8% |
| Net Income | ¥32.4B | ¥20.0B | +61.4% |
| ROE | 10.7% | 7.2% | - |
Executive Summary
Profit growth significantly outpaced revenue growth, making improved profitability the central theme of the current period’s performance. Revenue was ¥352.4B (+5.5% YoY), Operating Income was ¥45.1B (+47.6%), Ordinary Income was ¥46.4B (+56.8%), and quarterly Net Income attributable to owners of the parent was ¥32.4B (+61.4%). The Operating Income margin improved by approximately 3.7pt to 12.8%, from 9.2% in the same period of the previous year, primarily due to the sharp growth of the Electronic Materials Business and the return to profitability of the Machinery Business.
Factors Driving Performance Changes
【Revenue】Revenue was ¥352.4B (+5.5% YoY). By segment, the core Chemicals Business continued stable growth at ¥294.5B (+4.3%), accounting for 83.5% of total revenue. The Electronic Materials Business recorded a substantial increase in revenue to ¥18.3B (+63.7%), while the Machinery Business posted a slight decline in revenue to ¥30.2B (▲1.6%).
【Profit and Loss】Operating Income was ¥45.1B (+47.6% YoY), Ordinary Income was ¥46.4B (+56.8%), and Net Income was ¥32.4B (+61.4%). Segment profit was ¥41.6B for Chemicals (+21.6%), ¥5.6B for Electronic Materials (a sharp increase from ¥1.0B in the previous year), and ¥2.2B for Machinery (a return to profitability from a loss of ▲¥1.8B in the previous year), indicating improved profitability across all three businesses. Non-operating income and expenses resulted in a surplus of ¥1.3B, lifting Ordinary Income, while there were no significant extraordinary gains or losses. The tax burden coefficient was approximately 0.698, within the normal range, supporting the conclusion that both revenue and profit increased.
Segment Analysis
The Chemicals Business generated Revenue of ¥294.5B (83.5% composition ratio) and segment profit of ¥41.6B (14.1% margin, improved from 12.1% in the previous year), making it the largest contributor to profit. The Electronic Materials Business recorded Revenue of ¥18.3B (+63.7%) and segment profit of ¥5.6B (30.4% margin, sharply expanded from 9.0% in the previous year), making the largest contribution to the Company-wide profit increase. Although the Machinery Business posted Revenue of ¥30.2B (▲1.6%), segment profit recovered to ¥2.2B (a return to profitability from a loss of ▲¥1.8B in the previous year, with a 7.1% margin). Other Businesses (including catalyst regeneration for petroleum refining and real estate leasing) generated Revenue of ¥9.4B and profit of ¥5.8B, resulting in a high margin of 61.7%, although both declined from the previous year. Adjustments for Company-wide expenses and other items amounted to ▲¥10.1B, deteriorating from ▲¥8.9B in the previous year; the structure was one in which improved segment profitability absorbed the increase in Company-wide costs.
Key Financial Indicators
【Profitability】The Operating Income margin improved by approximately 3.7pt to 12.8%, from 9.2% in the previous year; the Net Income margin also improved to 9.2%, from approximately 6.0% in the previous year; ROE was 10.7%. 【Cash Quality】Accounts receivable were ¥122.4B, accounting for 25.4% of total assets. Together with inventories of ¥38.2B (products ¥38.2B, raw materials ¥25.0B, and work in process ¥10.7B), working capital was at a relatively substantial level. 【Investment Efficiency】The total asset turnover ratio remained at approximately 0.73x, while the capital-intensive asset structure, including Property, Plant and Equipment of ¥194.5B (40.4% of total assets), affected capital efficiency. Construction in progress of ¥25.6B accounted for 13.2% of Property, Plant and Equipment, and the commencement of operations in the future will be key to improving asset efficiency. 【Financial Soundness】The Equity Ratio rose to 62.9%, from 60.8% in the previous year, and net assets were ¥302.6B. Interest-bearing debt consisted of Short-Term Borrowings of ¥51.2B, exceeding Long-Term Borrowings of ¥25.8B, resulting in a debt structure weighted toward short-term borrowings.
Cash Flow Analysis
Although the Company has not disclosed a statement of cash flows, funding trends can be confirmed from changes in the balance sheet. Cash and deposits decreased to ¥38.6B from ¥50.5B in the same period of the previous year, while Property, Plant and Equipment increased to ¥194.5B from ¥178.3B, indicating that funds have been increasingly allocated to capital expenditures. Short-Term Borrowings increased to ¥51.2B from ¥43.4B in the previous year, while Long-Term Borrowings decreased to ¥25.8B from ¥40.0B, indicating a shift in the composition of interest-bearing debt toward the short term. Accounts receivable increased to ¥122.4B from ¥116.7B in the previous year, and the accumulation of working capital accompanying revenue growth is considered one factor behind the decline in cash and deposits. Retained earnings increased to ¥201.4B from ¥179.7B in the previous year, indicating continued accumulation of internally retained funds.
Earnings Quality
The increase in profit during the current period was centered on the expansion of Operating Income to ¥45.1B, with no extraordinary gains or losses recorded and no uplift attributable to temporary factors. Non-operating income was ¥3.6B, representing approximately 1.0% of Revenue, and consisted of recurring items such as dividend income of ¥0.4B and other income of ¥0.6B. Equity in earnings of affiliates was positive at ¥2.4B, expanding from ¥0.5B in the previous year and making a certain contribution to the increase in Ordinary Income. Comprehensive income was ¥34.2B, with the difference from Net Income of ¥32.4B limited to approximately ¥1.7B. The primary factors were valuation-related items such as foreign currency translation adjustments of ¥1.5B and valuation differences on other securities. The small gap between Net Income and Comprehensive Income indicates that the quality of current-period earnings was not significantly affected by fluctuations in gains and losses on valuation.
Earnings Forecast and Guidance
The full-year Company forecast is Revenue of ¥477.0B (+5.0% YoY), Operating Income of ¥58.0B (+22.5%), and Ordinary Income of ¥60.0B (+30.4%). The Q3 cumulative progress ratios were 73.9% for Revenue, 77.8% for Operating Income, 77.3% for Ordinary Income, and 77.0% for Net Income. Progress below Operating Income was slightly above the standard 75% level, while Revenue progress was broadly within the standard range. The required level for Q4 is approximately ¥124.6B in Revenue and approximately ¥12.9B in Operating Income. As this is below the Q3 cumulative Operating Income margin of 12.8%, achieving the full-year plan does not require excessively strong assumptions.
Shareholder Returns
The Q2 dividend was ¥64.00 per share, and the full-year forecast annual dividend is ¥170.00, implying a year-end dividend of ¥106.00 after deducting the interim dividend. The forecast Payout Ratio against forecast EPS of ¥537.61 is 31.6%, below the general sustainability benchmark of 60%. The simple Payout Ratio based on Q3 cumulative Net Income of ¥3.235B was only 15.7%. With substantial retained earnings of ¥201.4B and net assets of ¥302.6B, the dividend plan is consistent with the earnings forecast progress ratio of 77.0%.
Risk Factors
-
Working Capital and Funding Efficiency Risk: Accounts receivable were ¥122.4B, accounting for 25.4% of total assets. Annualized DSO was 95 days and CCC was 128 days, both exceeding cautionary benchmarks. The expansion of working capital during a period of revenue growth remains an issue requiring ongoing monitoring from a funding efficiency perspective.
-
Short-Term Liquidity Risk: Interest-bearing debt is centered on Short-Term Borrowings of ¥51.2B, while Cash and deposits of ¥38.6B represented only 0.75x Short-Term Borrowings. The short-term debt ratio is high, resulting in relatively high sensitivity to refinancing and changes in the financial environment.
-
Sustainability of Electronic Materials Business Growth Risk: The Electronic Materials Business achieved revenue growth of +63.7% YoY and rapidly expanded its margin to 30.4%. However, the business is susceptible to market conditions and changes in customers’ production plans, making the extent to which this high growth rate can be replicated in the full year and the subsequent period a key focus.
Industry Benchmarks (Reference; Compiled by the Company)
Industry Benchmarks (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 12.8% | 8.6% (4.3%–12.7%) | +4.2pt |
| Net Income Margin | 9.2% | 6.4% (2.8%–10.3%) | +2.8pt |
Both the Operating Income margin and Net Income margin exceed the industry median, indicating that profitability is relatively high within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 5.5% | 3.3% (-2.1%–8.9%) | +2.2pt |
The Revenue growth rate exceeds the industry median but does not reach the upper bound of the IQR (8.9%), placing the Company in the mid-to-upper range within the industry.
※Source: Compiled by the Company
Key Takeaways from the Financial Results
-
The profit growth rate (Operating Income +47.6%) significantly exceeded the revenue growth rate (+5.5%), indicating that, in addition to stable growth in the Chemicals Business, the sharp expansion of the Electronic Materials Business and the return to profitability of the Machinery Business drove the improvement in profit.
-
Progress ratios against the full-year Company forecast were 77.8% for Operating Income and 77.3% for Ordinary Income, slightly exceeding the standard 75% level. Together with Revenue progress of 73.9%, progress toward achieving the plan is generally on track.
-
While profitability indicators (Operating Income margin of 12.8% and ROE of 10.7%) improved both year on year and relative to the industry, working capital indicators such as DSO of 95 days and CCC of 128 days remain points to monitor regarding funding efficiency during a period of revenue growth.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥4,310 |
| base | ¥4,464 |
| bull | ¥4,589 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥3,874 |
| Adjusted Forecast EPS | ¥577.9 |
| Cost of Equity r | 9.77% (10-year Japanese Government Bond 2.77% + Equity Risk Premium 6.00% + Size Premium 1.00%) |
| Persistence Factor of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 31.6% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the track record of guidance achievement rates for companies in the same industry) |
| Implied PBR / PER | 1.15x / 7.7x |
Sensitivity: ¥4,338–¥4,595 at Cost of Equity ±1%; ¥4,450–¥4,485 at ω±0.1.
Notes:
- Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
- Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee the future share price.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was strong, with modest revenue growth translating into substantially faster profit growth and a raised level of segment profitability. Revenue increased 5.5% YoY to ¥35.24bn. Operating income rose 47.6% to ¥4.51bn, materially outpacing sales growth. Ordinary income increased 56.8% to ¥4.64bn. Net income attributable to owners rose 61.4% to ¥3.24bn, and EPS reached ¥414.26. Gross profit expanded 20.8% YoY to ¥8.17bn despite only a 1.7% increase in cost of sales. The gross margin improved by 290bp YoY to 23.2% from 20.2%. The operating margin expanded by 365bp to 12.8% from 9.2%, indicating favorable gross-profit leverage and lower SG&A intensity. SG&A expenses declined 1.3% YoY to ¥3.66bn while revenue increased, creating meaningful operating leverage. The net margin improved by approximately 320bp YoY to 9.2% from 6.0%. Profit before tax and ordinary income were identical at ¥4.64bn, indicating no material extraordinary item affected current-period earnings. Non-operating income was ¥0.36bn, equivalent to only 1.0% of sales, and therefore did not drive the earnings acceleration. Equity-method earnings increased to ¥0.24bn from ¥0.05bn, contributing to the improvement in non-operating profitability but remaining modest relative to operating income. The core Chemicals business remained the principal earnings engine, generating ¥4.16bn of segment profit, while the Machinery business returned to profit and Electronic Materials delivered a sharp profit increase. Full-year sales progress is 73.9%, broadly consistent with the normal 75% Q3 benchmark. Operating-income progress is 77.8%, 2.8 percentage points ahead of the seasonal benchmark, leaving the company positioned to achieve its ¥5.80bn full-year operating-income forecast if the current margin structure is maintained. Receivables collection and the cash conversion cycle are the principal operating-finance areas to monitor, as elevated working-capital duration could constrain cash realization despite strong accounting earnings.
Profitability Analysis
Annualized ROE is 14.2%, composed of a 9.2% net profit margin, 0.977x annualized asset turnover, and 1.59x financial leverage. The largest positive change in the return profile is margin expansion rather than aggressive leverage: the operating margin increased 365bp YoY to 12.8%, while the balance sheet remains conservatively financed at 0.59x debt-to-equity. The 9.2% net margin is within the good 5-10% range and approaches the 10% excellent threshold. Gross-margin expansion to 23.2% was the fundamental driver, as gross profit increased ¥1.41bn while revenue grew ¥1.85bn. Operating leverage amplified this benefit because SG&A declined by ¥0.05bn YoY, reducing SG&A as a percentage of sales to 10.4% from 11.1%. The Chemicals business is the core business, accounting for ¥29.45bn of revenue, or 83.6% of consolidated sales, and ¥4.16bn of segment profit, or 75.5% of total segment profit before corporate costs. Chemicals segment revenue grew 4.3% YoY and segment profit increased 21.6% to ¥4.16bn, with segment margin improving to 14.1% from 12.1%. Machinery revenue declined 1.6% to ¥3.02bn, but segment profit improved from a ¥0.18bn loss to a ¥0.22bn profit, implying a turnaround in profitability. Electronic Materials revenue rose 63.7% to ¥1.83bn and segment profit increased 456.0% to ¥0.56bn; its segment margin improved to 30.4% from 9.0%, though the smaller revenue base makes this contribution potentially more variable. Other businesses recorded revenue of ¥0.94bn, down 3.3%, and segment profit of ¥0.58bn, down 3.8%, with a high 61.7% segment margin. Unallocated corporate expenses increased to ¥1.01bn from ¥0.89bn, but this increase was substantially smaller than the ¥1.57bn increase in aggregate segment profit. The tax burden was 0.698, corresponding to a 30.2% effective tax rate, which modestly constrained conversion from pre-tax to net profit but remains broadly normal. Interest burden was 1.028x because non-operating income exceeded interest and other non-operating expenses; interest coverage was very strong at 49.02x. The margin gains appear operationally supported rather than driven by non-recurring gains, although sustaining the exceptional Electronic Materials margin expansion is important to maintaining the group trajectory.
Growth Assessment
Revenue growth of 5.5% was led by Electronic Materials, where sales increased ¥0.71bn YoY, followed by Chemicals, where sales increased ¥1.22bn. Chemicals remains the main determinant of consolidated growth because of its 83.6% revenue share. The Machinery segment's revenue contraction means that its earnings recovery was driven by improved project profitability, mix, or cost execution rather than top-line expansion. Group operating income grew 47.6%, nearly nine times the rate of revenue growth, demonstrating a favorable profit mix and cost leverage. The ¥1.45bn increase in operating income exceeded the ¥1.41bn increase in gross profit only after a ¥0.05bn reduction in SG&A, confirming that both production economics and overhead discipline contributed. Full-year company guidance calls for 5.0% sales growth, 22.5% operating-income growth, and 30.4% ordinary-income growth. At Q3, sales are 73.9% of the ¥47.70bn full-year forecast, only 1.1 percentage points below the standard 75% progress rate. Operating income is 77.8% of the ¥5.80bn forecast, 2.8 percentage points ahead of the standard rate. Ordinary income is 77.3% of the ¥6.00bn forecast, 2.3 percentage points ahead of the standard rate. Net income is 77.0% of the ¥4.20bn forecast, 2.0 percentage points ahead of the benchmark. The remaining implied Q4 requirement is ¥12.46bn of revenue, ¥1.29bn of operating income, ¥1.36bn of ordinary income, and ¥0.97bn of net income. This implies a required Q4 operating margin of approximately 10.4%, below the Q3 cumulative 12.8% margin, providing a reasonable cushion against some normalization. Revenue sustainability nevertheless depends primarily on continued Chemicals demand and on retaining the improved profitability in Machinery and Electronic Materials. Construction in progress of ¥2.56bn, equal to 13.2% of PPE, signals a meaningful manufacturing investment pipeline that could support future capacity or modernization.
Financial Health
Liquidity is sound, with a current ratio of 198.8%, a quick ratio of 167.2%, and working capital of ¥11.92bn. Current assets of ¥23.98bn substantially exceed current liabilities of ¥12.06bn. Cash and deposits of ¥3.86bn cover 0.75x short-term loans of ¥5.12bn, so cash alone does not fully cover near-term borrowings; however, liquid receivables of ¥12.24bn and the strong quick ratio provide substantial additional coverage. Short-term debt represents 66.5% of interest-bearing debt, triggering refinancing risk because the company relies materially on rolling over short-duration funding. The refinancing risk is moderated by the strong current ratio, ¥11.92bn of net working capital, modest debt-to-equity of 0.59x, and very high 49.02x interest coverage. Interest-bearing debt totals ¥7.70bn, equal to 20.3% of capital, which is below the 40% investment-grade covenant benchmark. Total liabilities declined slightly to ¥17.85bn while total equity increased 8.6% YoY to ¥30.26bn. The equity ratio improved to 62.9% from 60.8%, enhancing balance-sheet resilience. Long-term loans fell ¥1.42bn, or 35.6% YoY, to ¥2.58bn, reducing longer-term leverage but increasing the relative concentration of debt in short-term facilities. Retained earnings increased ¥2.17bn YoY to ¥20.14bn, supported by strong earnings generation. Net defined benefit liability was ¥2.56bn, representing a meaningful long-term obligation that should remain monitored alongside debt. PPE represents 40.4% of total assets, reflecting a capital-intensive manufacturing asset base, while land accounts for ¥6.82bn of the ¥19.45bn PPE balance. Investment securities of ¥3.51bn represent 7.3% of assets and provide some balance-sheet value exposure to market-price movements. There are no material goodwill-related balance-sheet risks indicated by the reported intangible asset balance of only ¥0.49bn, or 0.1% of assets.
Notable B/S Changes
Long-term loans: -¥1.42bn (-35.6%) YoY to ¥2.58bn - lowers long-term leverage, but also leaves debt funding more concentrated in short-term facilities. Construction in progress: +¥1.85bn (+258.0%) YoY to ¥2.56bn - indicates a significant manufacturing investment pipeline; completion timing and returns on invested capital should be monitored. Raw materials: +¥0.72bn (+40.6%) YoY to ¥2.50bn - increases exposure to procurement timing, commodity costs, and demand-alignment risk. Property, plant and equipment: +¥1.66bn (+9.3%) YoY to ¥19.45bn - reflects ongoing expansion or modernization of a capital-intensive manufacturing asset base. Retained earnings: +¥2.17bn (+12.1%) YoY to ¥20.14bn - strengthens internal funding capacity and dividend support.
Cash Flow Quality
The earnings profile is operationally strong, as current-period profit before tax equals ordinary income and operating income accounts for the predominant share of earnings. Operating income of ¥4.51bn exceeds the ¥0.13bn net non-operating contribution by a wide margin, limiting dependence on financial or investment income. Dividend income was only ¥0.04bn, or 0.1% of sales, and equity-method earnings were ¥0.24bn, so neither is the main source of reported profitability. Receivable days are 95 days on an annualized basis, above the 60-day warning threshold and indicating slow cash collection relative to revenue recognition. Accounts receivable increased ¥0.57bn YoY to ¥12.24bn, broadly tracking revenue growth but remaining substantial at 25.4% of total assets. The annualized cash conversion cycle is 128 days, above the 120-day warning threshold, which heightens the risk that profit conversion into cash lags reported earnings. This long cycle is particularly relevant for a chemicals and industrial manufacturing group, where customer credit terms, project milestones, and inventory availability can absorb cash. Accounts payable increased ¥0.70bn YoY to ¥4.14bn, providing some supplier-financing support but not offsetting the elevated receivables burden. Inventory composition includes ¥2.50bn of raw materials, ¥1.07bn of work in process, and ¥3.82bn of finished goods, while raw-material inventory increased 40.6% YoY. The expansion in raw-material balances should be monitored for procurement timing, input-cost exposure, and the risk of slower conversion should demand soften. The company should demonstrate that receivables collection improves and that the 128-day annualized cash conversion cycle declines as sales are realized. Strong profitability alone does not eliminate this working-capital risk, particularly while 66.5% of debt is short term.
Dividend Sustainability
The FY2026 full-year dividend forecast is ¥170 per share, compared with forecast EPS of ¥537.61. The implied full-year dividend payout ratio is approximately 31.6%, which is well below the 60% sustainability benchmark. The Q2 dividend of ¥64 per share represented a calculated 15.7% payout against Q3 cumulative net income. The implied year-end dividend is ¥106 per share, assuming the full-year ¥170 dividend forecast is maintained. Retained earnings of ¥20.14bn and total equity of ¥30.26bn provide a substantial capital base for the stated dividend. The balance sheet also remains conservatively leveraged, with debt-to-equity of 0.59x and debt-to-capital of 20.3%. The full-year net-income forecast of ¥4.20bn provides adequate accounting-profit coverage for the projected dividend. Dividend sustainability will ultimately depend on maintaining operating cash realization, with receivables days and the cash conversion cycle being the main factors to monitor. No conclusion on free-cash-flow coverage is required to support the stated payout assessment because the payout ratio and capital structure are conservative.
Risk Assessment
Business risks include Chemicals concentration: the Chemicals business contributes 83.6% of revenue and 75.5% of aggregate segment profit before corporate costs, making group earnings sensitive to chemical-market demand, selling prices, raw-material costs, and plant operating stability., Electronic Materials variability: segment sales rose 63.7% YoY and margin reached 30.4%, creating a strong contribution but also raising sensitivity to semiconductor/electronics demand cycles and the sustainability of a sharp margin step-up., Machinery execution risk: the segment returned from a ¥0.18bn loss to a ¥0.22bn profit despite a 1.6% revenue decline, so the recovery must be validated through continued order execution and project-margin discipline., Working-capital risk: annualized DSO of 95 days and an annualized cash conversion cycle of 128 days indicate slow conversion of sales into cash and elevate exposure if customer collections weaken., Manufacturing and chemical-industry risk: fluctuations in raw-material and energy costs, environmental compliance requirements, production disruptions, product quality incidents, and customer demand volatility can pressure margins and working capital..
Financial risks include Refinancing risk: 66.5% of interest-bearing debt is short term, above the 40% alert threshold. The company therefore depends materially on renewal of short-term facilities, although liquidity ratios, modest leverage, and 49.02x interest coverage mitigate near-term stress., Receivables concentration in assets: trade receivables equal 25.4% of total assets and ¥12.24bn, making liquidity and cash conversion sensitive to collection timing and customer credit quality., Defined-benefit obligation: the ¥2.56bn net defined benefit liability is a material non-debt long-term obligation that can be affected by discount rates, investment returns, and actuarial assumptions., Capital investment execution: construction in progress of ¥2.56bn, equal to 13.2% of PPE, requires timely completion and adequate returns to avoid capital being tied up without earnings contribution..
Key concerns include Highest priority: reduce annualized DSO from 95 days and the annualized cash conversion cycle from 128 days, as these are the clearest constraints on earnings-to-cash conversion., High priority: manage the maturity profile of ¥7.70bn interest-bearing debt, especially the ¥5.12bn short-term loan balance, while preserving liquidity., Medium priority: assess whether Electronic Materials can retain its 30.4% segment margin and whether Machinery can sustain profitability after returning to the black., Medium priority: monitor raw-material inventory, which increased 40.6% YoY to ¥2.50bn, for demand alignment and commodity-price exposure., Positive offsets are the 62.9% equity ratio, 198.8% current ratio, 0.59x debt-to-equity ratio, and 49.02x interest coverage..
Investment Implications
Key takeaways include Operating income increased 47.6% YoY to ¥4.51bn on 5.5% revenue growth, driven by a 365bp operating-margin expansion to 12.8%., Chemicals is the core business and remains highly profitable, while Machinery's move into profit and Electronic Materials' sharp growth broadened the earnings base., Q3 cumulative progress is ahead of the normal seasonal pace for operating income, ordinary income, and net income relative to full-year guidance., Capital structure is sound, with 62.9% equity ratio, 0.59x debt-to-equity, 20.3% debt-to-capital, and 49.02x interest coverage., The central counterweight to strong reported earnings is working-capital efficiency, reflected in 95 annualized receivable days and a 128-day annualized cash conversion cycle., The implied FY2026 dividend payout ratio of approximately 31.6% appears conservative relative to forecast earnings and retained earnings..
Metrics to watch include Chemicals segment revenue growth and segment margin, Electronic Materials revenue growth and the durability of its 30.4% segment margin, Machinery segment order execution and sustained positive segment profit, Annualized DSO, annualized cash conversion cycle, and the receivables balance, Raw-material inventory growth and customer-demand alignment, Short-term loan refinancing, cash-to-short-term-debt coverage, and debt maturity composition, Completion and return profile of ¥2.56bn construction in progress, Q4 operating margin versus the approximately 10.4% margin required to achieve full-year guidance.
Regarding relative positioning, The company combines good annualized ROE of 14.2%, a good 12.8% operating margin, strong interest coverage, and conservative balance-sheet leverage. Its principal relative limitation is less efficient working-capital conversion, with annualized DSO and the annualized cash conversion cycle above standard manufacturing warning thresholds. The absence of material goodwill and the low 0.1% intangible-assets-to-assets ratio limit acquisition-accounting and impairment-related balance-sheet complexity.